The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prevalence of symptomatic skeletal events (SSE) with reduced denosumab (Dmab) dose density (every 12 weeks versus every 4 weeks): A randomized phase III non-inferiority trial SAKK 96/12 REDUSE.
 
Roger Von Moos
Honoraria - Amgen; Lilly; Roche
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb; Gilead Sciences (Inst); GlaxoSmithKline (Inst); InnoMedica (Inst); Lilly; Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); PharmaMar; Roche; Seagan (Inst)
Travel, Accommodations, Expenses - PharmaMar; Takeda
 
Andreas Müller
Honoraria - Novartis
Consulting or Advisory Role - Abbvie; AstraZeneca; Daiichi Sankyo/Schweiz; Gilead Sciences; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche Schweiz AG
Speakers' Bureau - Novartis
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Gilead Sciences; Gilead Sciences
 
Stefanie Hayoz
No Relationships to Disclose
 
Michael Mark
Consulting or Advisory Role - AstraZeneca; bms; Johnson & Johnson/Janssen; MSD Oncology; Pfizer; PharmaMar; Roche
Research Funding - Gilead Sciences (Inst); Swiss Cancer Research Foundation (Inst)
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen (Inst); Merck (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst)
 
Stefanie Fischer
Consulting or Advisory Role - Amgen
Speakers' Bureau - Johnson & Johnson/Janssen
Research Funding - Astellas Pharma; MSD Oncology
Travel, Accommodations, Expenses - Bayer
 
Razvan Popescu
Consulting or Advisory Role - AstraZeneca; Gosta Labs (Inst); Immedica; Kaiku Health (Inst); Kaiku Health (Inst); Novartis (Inst); Takeda (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Menarini Group (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Sacha Rothschild
Honoraria - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Otsuka (Inst); Pfizer (Inst); PharmaMar (Inst); Roche Diagnostics Solutions (Inst); Roche Pharma AG (Inst); Sanofi (Inst); Takeda (Inst)
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo Europe GmbH (Inst); Eisai (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Otsuka (Inst); Pfizer (Inst); PharmaMar (Inst); Roche Pharma AG (Inst); Takeda (Inst); Thermo Fisher Scientific (Inst)
Speakers' Bureau - Amgen (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Johnson & Johnson/Janssen (Inst); Roche Pharma AG (Inst); Sanofi/Aventis (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Revolution Medicines (Inst); Roche Pharma AG (Inst); Thermo Fisher Scientific (Inst)
Travel, Accommodations, Expenses - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Roche Pharma AG (Inst); Sanofi; Takeda (Inst)
Other Relationship - Federal Drug Commission of the Swiss Federal Office of Public Health; Swiss Cancer Institute (SCI) (Inst)
 
Mathias Fehr
Stock and Other Ownership Interests - Novartis; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca
Travel, Accommodations, Expenses - Gilead Sciences; PharmaMar
 
Claudine Egger
Travel, Accommodations, Expenses - BeiGene; Ipsen; Pierre Fabre
 
Sandro Anchisi
No Relationships to Disclose
 
Florian Schmid
No Relationships to Disclose
 
Khalil Zaman
Consulting or Advisory Role - AstraZeneca (Inst); Daiichi (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst)
Other Relationship - Daiichi Sankyo Europe GmbH (Inst); Pierre Fabre (Inst); Roche/Genentech (Inst)
 
Christoph Ackermann
Consulting or Advisory Role - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Hubert Kugler
Consulting or Advisory Role - Stemline Therapeutics Switzerland GmbH
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Pfizer
 
Priska Bützberger
No Relationships to Disclose
 
Catrina Uhlmann
Stock and Other Ownership Interests - Roche
Consulting or Advisory Role - Lilly; Pierre Fabre
 
Marc Küng
No Relationships to Disclose
 
Simone Wyss
No Relationships to Disclose
 
Arnoud Templeton
Honoraria - Johnson & Johnson/Janssen
Consulting or Advisory Role - Janssen (Inst); MSD (Inst)
 
Silke Gillessen
Employment - Ente Ospedaliero Cantonale
Honoraria - Avalere Health (Inst); EPG Health (Inst); Medtoday Switzerland (Inst)
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BMS (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); LinkinVax (Inst); Macrogenics (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); PeerVoice (Inst); Pfizer (Inst)
Speakers' Bureau - Emirates Oncology Society (Inst); ESMO (Inst); ESMO (Inst); Intellisphere (Inst); Meister ConCept GmbH (Inst); Orikata (Inst); Schweizerische Gesellschaft für Medizinische Onkologie; Silvia Grasso Consulting (Inst); Swiss Cancer Institute (Inst); SwissInfoMed (Inst); Symposia Congressi (Inst); UroPratica Group in São Paulo (Inst)
Patents, Royalties, Other Intellectual Property - Method for biomarker (WO 3752009138392 A1); WO2009138392
Travel, Accommodations, Expenses - Bayer; Gilead Sciences; Intellisphere; Johnson & Johnson/Janssen
Other Relationship - University of Applied Sciences and Arts of Southern Switzerland (SUPSI)